Appendix 4D and Half Year Financial Report
Filed with ASX · · 32 pages · English
Summary by 6ix AI
The report highlights significant advancements in the company's quantum projects, including successful electrical readout of quantum states and partnerships aimed at accelerating technology development. Despite a reported loss for the period, Archer maintains a strong cash position to support ongoing research and development activities. The Executive Chair emphasized the company's focus on integrating recent technological advances into functional prototypes and preparing for clinical trials.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Archer Materials Limited on 6ix
Earlier from Archer Materials
- Archer develops early Biochip prototype
- Quarterly Activities/Appendix 4C Cash Flow Report
- AXE achieves readout milestone towards qubit demonstration
- AXE & CSIRO - Quantum Machine Learning for fraud detection
- Silicon Biochip meets performance and clinical requirements
Later from Archer Materials
- Archer Materials Investor Webinar: First Half FY26 Update & Quantum Technology Developments
- Biochip advances toward beta prototype & clinical validation
- Archer strengthens pathway to quantum device manufacturing
- Biosensor beta prototype and manufacturing pathway advanced
- Archer QML Project achieves key milestones
Follow Archer Materials into a list and get an email when it puts out news.
Follow Archer Materials